Cree, Bruce A C

Mayo Clinic

From the Department of Neurology (B.G.W.), Mayo Clinic, Rochester, MN; MedImmune Ltd. (G.B., A.F.), Riverside Building, Granta Park, Great Abington, Cambridge, UK; Guthy-Jackson Foundation (J.M.B., K.V.H.), San Diego, CA; Departments of Neurology and Ophth

Citations 2

Disability Outcomes in the N-MOmentum Trial of Inebilizumab in Neuromyelitis Optica Spectrum Disorder

Neurology Neuroimmunology & Neuroinflammation | March 26, 2021 | Volume: 8 | Issue: 3 | Pages: No page available

10.1212/nxi.0000000000000978 | PMID 33771837

Challenges and opportunities in designing clinical trials for neuromyelitis optica

Neurology | April 4, 2015 | Volume: 84 | Issue: 17 | Pages: 1805-1815

10.1212/wnl.0000000000001520 | PMID 25841026